Granisetron
GRANISETRON HYDROCHLORIDE
- Strength
- 1 mg/mL
- Form
- Injection, Solution
- Class
- Serotonin-3 Receptor Antagonist
Fresenius Kabi USA, LLC
granisetron
Listed by Heron Therapeutics, Inc.
| Dosage form | Injection |
|---|---|
| Route | Subcutaneous |
| Drug class | Serotonin-3 Receptor Antagonist |
| Approval route | NDA — original brand approval |
| NDC code | 47426-101 |
| FDA application | NDA022445 |
| RxNorm concept | 1810484 |
| Package sizes listed | 1 |
| Marketed since | August 2016 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
GRANISETRON HYDROCHLORIDE
Fresenius Kabi USA, LLC
Hikma Pharmaceuticals USA Inc.
Eugia US LLC
Eugia US LLC
Hikma Pharmaceuticals USA Inc.
Bionpharma Inc.
Breckenridge Pharmaceutical, Inc.
Mylan Institutional LLC
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.